SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : progenics
PGNX 4.100-9.4%Jun 19 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (74)5/4/2004 11:14:01 AM
From: keokalani'nui   of 139
 
pro140, it's about time!

>>"Whereas the small-molecule inhibitors are antagonists that also block the natural activity of CCR5, PRO 140 inhibited HIV infection without CCR5 receptor antagonism in laboratory studies. In addition, PRO 140 recognized a different region of CCR5 and thus may be active against viruses that are resistant to small-molecule CCR5 antagonists.<<

Meaning: investors please don't abandon us for pfe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext